Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.175

Low Lung Cancer Resection Rates in a Tertiary Level Thoracic Center in Nepal - Where Lies Our Problem?  

Thapa, Bibhusal (ManMohan Cardio-Thoracic Vascular and Transplant Center)
Sayami, Prakash (ManMohan Cardio-Thoracic Vascular and Transplant Center)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 175-178 More about this Journal
Abstract
Background: Resection rates of lung cancer are low in general and especially in countries like Nepal. Advanced stage at presentation and poor general condition of the patient are the usual causes. Materials and Methods: In this prospective observational study, one hundred cases of lung cancer who presented at the Thoracic Surgery Unit between October 2011 and October 2012 were included. Results: Those aged in the $6^{th}$ and $7^{th}$ decades together accounted for 72/100 patients. The male to female ratio was 2:1. There was a mean-$29.2{\pm}14.2$ pack yrs smoking history with only five non-smokers. Seventy-six patients presented with locally advanced disease while 21 had metastases. Only three had local disease. The average time between onset of symptoms to first contact with a doctor was $2.3{\pm}5.3$ months (range: 0-35.6 months). Average time between first contact to referral was $50.4{\pm}65.7$ days (range-0-365). Only three patients were resected, one after neo-adjuvant chemotherapy. Advanced disease was the cause of unresectability in 95 cases. One of three patients with local disease had pulmonary functions allowing the warranted resection. $N_2$ disease with $T_{1-3}$ on CT scan was found in 47. Three of these patients underwent mediastinoscopy and all confirmed uninvolved $N_2$. Conclusions: Lung resection rates in our center remain low. Late presentation leading to advanced disease and poor pulmonary reserves preclude resection in most cases. More liberal use of mediastinal staging and better assessment of pulmonary functions may allow us to improve resection rates.
Keywords
Lung cancer; mediastinoscopy; pulmonary functions; resection;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Olsen GN (1989). The evolving role of exercise testing prior to lung resection. Chest, 95, 218.   DOI
2 Petty TL (2001). Simple office spirometry. Clin Chest Med, 22, 845-59.   DOI
3 Riaz SP, Luchtenborg M, Jack RH, et al (2012). Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer, 48, 54-60.
4 Rich AL, Tata LJ, Free CM, Stanley RA, et al (2011). Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax. 66, 1078-84.   DOI
5 Sayami P, Singh BM, Koirala B, Sharma GP (1997). Surgery of lung cancer in Tribhuvan University Teaching Hospital. JNMA, 35, 182-5.
6 Win T, Jackson A, Sharples L (2005). Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J, 25, 594.   DOI
7 Crawford SM, Sauerzapf V, Haynes R, Zhao H, Forman D et al (2009). Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer, 101, 897-901.   DOI
8 Damhuis RAM, Schutte PR (1995). Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J, 9, 8-11.
9 Dransfield MT, Lock BJ, Garver RI Jr (2006). Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System. Clin Lung Cancer, 7, 268-72.   DOI
10 Ellis PM, Vandermeer R (2011). Delays in the diagnosis of lung cancer. J Thorac Dis, 3, 183-8.
11 Jensen AR, Mainz J, Overgaard J (2002). Impact of delay on diagnosis and treatment of primary lung cancer. Acta Ontol, 24, 147-52.
12 Chandra S, Mohan A, Guleria R, Singh B, Yadav P (2009). Delays during the diagnostic evaluation and treatment of lung cancer. Asian Pac J Cancer Prev, 10, 453-6.
13 Coleman MP, Forman D, Bryant H (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995e2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38.   DOI   ScienceOn
14 Wouters MW, Siesling S, Jansen-Landheer ML, et al (2010). Variation in treatment and outcome in patients with nonsmall cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol, 36, 83-92.   DOI
15 Billing JS, Wells FC (1996). Delays in the diagnosis and surgical treatment of lung cancer. Thorax, 51, 903-6.   DOI
16 Bozcuk H, Martin C (2001). Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer, 34, 243-52.   DOI
17 Crapo RO, Morris AH (1989). Pulmonary function testing: sources of error in measurement and interpretation. South Med J, 82, 875-9.   DOI
18 Margolis ML, Montoya FJ, Palma WR Jr (1997). Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J, 90, 1187-91.   DOI
19 Graham EA, Singer JJ (1933). Successful removal of an entire lung for carcinoma of the bronchus. J Am Med Assoc, 101, 1371-3.   DOI
20 Kerr KM, Lamb D,Wathen CG, Walker WS, Douglas NJ (1992). Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax, 47, 337-41.   DOI
21 Khakwani A, Rich AL, Powell HA, et al (2013). Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit. Br J Cancer, 109, 2058-65.   DOI
22 Myrdal G, Lambe M, Hillerdal G (2004). Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax, 59, 45-9.